8-K: agilon health Holds Annual Meeting, Elects Directors
Annual Meeting Results
agilon health, inc. announced the results of its annual meeting of stockholders held on June 2, 2026, including the election of three Class II directors and the ratification of its independent auditor.
Summary
- The Company held its annual meeting of stockholders on June 2, 2026.
- Three Class II directors were elected to serve until the 2029 annual meeting.
- Ernst & Young LLP was ratified as the independent registered public accounting firm for the fiscal year ending December 31, 2026.
- Stockholders approved, on an advisory, non-binding basis, the compensation of named executive officers.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, indicating smooth operational governance and shareholder alignment on key procedural matters.
Positives
- Election of directors passed with significant majority votes.
- Ratification of the independent auditor, Ernst & Young LLP, was overwhelmingly approved.
- Advisory vote on executive compensation was approved by a substantial margin.
Future Outlook
The filing does not contain specific forward-looking statements or guidance beyond the ratification of the auditor for the fiscal year ending December 31, 2026.
Industry Context
StockSavvy.ai notes that the annual meeting results, particularly the election of directors and ratification of auditors, are standard procedural events for publicly traded companies. The strong approval margins for these proposals suggest continued shareholder confidence in the current governance structure.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Class II Director | N/A | Diana McKenzie | 2026-06-02 | Election at annual meeting |
| Class II Director | N/A | Karen McLoughlin | 2026-06-02 | Election at annual meeting |
| Class II Director | N/A | Ronald Williams | 2026-06-02 | Election at annual meeting |
Stakeholder Impact
- Shareholders: Confirmation of board composition and auditor provides stability and assurance in corporate governance.
- Management: Approval of executive compensation on an advisory basis indicates shareholder support for current compensation structures.
Next Steps
- The newly elected Class II directors will serve until the 2029 annual meeting.
- Ernst & Young LLP will serve as the independent registered public accounting firm for the fiscal year ending December 31, 2026.
Key Dates
| Date | Description |
|---|---|
| 2026-06-02 | Date of the annual meeting of stockholders and earliest event reported. |
| 2026-12-31 | Fiscal year end for which Ernst & Young LLP was appointed as independent auditor. |
| 2029-01-01 | Year until which newly elected Class II directors will serve. |
| 2026-06-03 | Date the report was signed. |
Keywords
agilon health, annual meeting, stockholders, board of directors, independent auditor, executive compensation, corporate governance, SEC filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.